Infection-mimicking materials to program dendritic cells in situ
Omar Abdel-Rahman Ali,Nathaniel Huebsch,Nathaniel Huebsch,Lan Cao,Glenn Dranoff,David J. Mooney,David J. Mooney +6 more
454
TL;DR: It is demonstrated that polymers can be designed to first release a cytokine to recruit and house host dendritic cells (DCs), and subsequently present cancer antigens and danger signals to activate the resident DCs and dramatically enhance their homing to lymph nodes.
read more
Abstract: Cancer vaccines typically depend on cumbersome and expensive manipulation of cells in the laboratory, and subsequent cell transplantation leads to poor lymph node homing and limited efficacy. We propose that materials mimicking key aspects of bacterial infection may instead be used to directly control immune cell trafficking and activation in the body. It is demonstrated that polymers can be designed to first release a cytokine to recruit and house host dendritic cells (DCs), and subsequently present cancer antigens and danger signals to activate the resident DCs and dramatically enhance their homing to lymph nodes. Specific and protective anti-tumor immunity was generated with these materials, as 90% survival was achieved in animals that otherwise die from cancer within 25 days. These materials show promise as cancer vaccines, and more broadly suggest that polymers may be designed to program and control the trafficking of a variety of cell types in the body.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Self-healing microcapsules synergetically modulate immunization microenvironments for potent cancer vaccination
Xiaobo Xi,Tong Ye,Shuang Wang,Na Xiangming,Jianghua Wang,Shuang Qing,Xiaoyong Gao,Changlong Wang,Feng Li,Wei Wei,Guanghui Ma +10 more
TL;DR: A novel microcapsule-based formulation for high-performance cancer vaccinations with special self-healing feature provides a mild and efficient paradigm for antigen microencapsulation that effectively increase the antigen utilization, improve the antigen presentation, and activate antigen presenting cells.
71
Nanoparticle design to induce tumor immunity and challenge the suppressive tumor microenvironment
TL;DR: This review focuses on how nano- and micromaterials can be used to induce antitumor immune responses and what their role in overcoming immune suppression could be.
70
Inflammatory cytokines presented from polymer matrices differentially generate and activate DCs in situ.
TL;DR: It is demonstrated that 3D polymer matrices modified to present inflammatory cytokines may be utilized to effectively mobilize and activate different DC subsets in vivo for immunotherapy.
Biocompatibility Evolves: Phenomenology to Toxicology to Regeneration.
TL;DR: A review/perspective article by as mentioned in this paper explores the biocompatibility etymological conundrum by reviewing the history of the concepts around bi-critatibility, today's standard methods for assessing bi-compatibility, a contemporary view of the foreign body reaction and finally, a compendium of new biomaterials that heal without the foreign-body capsule.
69
Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.
TL;DR: This review surveys the latest studies on engineering biomimetic materials for immunotherapy, focusing on the perspectives of bioengineering artificial antigen presenting cells and lymphoid organs.
67
References
Dendritic cells and the control of immunity
TL;DR: Once a neglected cell type, dendritic cells can now be readily obtained in sufficient quantities to allow molecular and cell biological analysis and the realization that these cells are a powerful tool for manipulating the immune system is realized.
15.2K
Vaccination with Irradiated Tumor Cells Engineered to Secrete Murine Granulocyte-Macrophage Colony-Stimulating Factor Stimulates Potent, Specific, and Long-Lasting Anti-Tumor Immunity
Glenn Dranoff,Elizabeth M. Jaffee,Audrey J. Lazenby,Paul Golumbek,Hyam I. Levitsky,Katja Brose,Valerie Jackson,Hirofumi Hamada,Drew M. Pardoll,Richard C. Mulligan +9 more
TL;DR: The results have important implications for the clinical use of genetically modified tumor cells as therapeutic cancer vaccines and the levels of anti-tumor immunity reported previously in cytokine gene transfer studies involving live, transduced cells could be achieved through the use of irradiated cells alone.
3K
Dendritic cells: specialized and regulated antigen processing machines.
Ira Mellman,Ralph M. Steinman +1 more
TL;DR: Dendritic cells are adept at endocytosis and express relatively low levels of surface MHC class I and II products and costimu-latory molecules, but can take up antigen tive responses critical for resistance to infections and but do not present it efficiently to T cells.
2.4K
Taking dendritic cells into medicine
TL;DR: Some medical implications of DC biology that account for illness and provide opportunities for prevention and therapy are presented.
2.1K
Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic Sites
Marie-Caroline Dieu,Béatrice Vanbervliet,Alain Vicari,J M Bridon,Elisabeth Oldham,Smina Ait-Yahia,Francine Brière,Albert Zlotnik,Serge Lebecque,Christophe Caux +9 more
TL;DR: The observation that CCR6 mRNA expression decreases progressively as DCs mature, whereas CCR7 mRNA expression is sharply upregulated, provides a likely explanation for the changes in chemokine responsiveness, and suggests a role for MIP-3α/CCR6 in recruitment of immature DCs at site of injury and for Mip-3β/CCr7 in accumulation of antigen-loaded mature DCs in T cell–rich areas.
1.5K